Trace minerals are commonly supplemented in the diets of farmed animals in levels exceeding biological requirements, resulting in extensive fecal excretion and environmental losses. Chelation of trace metal supplements with ethylenediaminetetraacetic acid (EDTA) can mitigate effects of dietary antagonists by preserving the solubility of trace minerals. Lack of EDTA biodegradability, however, is of environmental concern. L-glutamic acid, N,N-diacetic-acid (GLDA) is a readily biodegradable chelating agent that could be used as a suitable alternative to EDTA. The latter was tested in sequential dose response experiments in broiler chickens. Study 1 compared the effect of EDTA and GLDA in broilers on supplemental zinc availability at three levels of added zinc (5, 10 and 20 ppm) fed alone or in combination with molar amounts of GLDA or EDTA equivalent to chelate the added zinc, including negative (no supplemental zinc) and positive (80 ppm added zinc) control treatments. Study 2 quantified the effect of GLDA on the availability of native trace mineral feed content in a basal diet containing no supplemental minerals and supplemented with three levels of GLDA (54, 108 and 216 ppm). In study 1, serum and tibia Zn clearly responded to the increasing doses of dietary zinc with a significant response to the presence of EDTA and GLDA (P<0.05). These results are also indicative of the equivalent nutritional properties between GLDA and EDTA. In study 2, zinc levels in serum and tibia were also increased with the addition of GLDA to a basal diet lacking supplemental trace mineral, where serum zinc levels were 60% higher at the 216 ppm inclusion level. Similar to the reported effects of EDTA, these studies demonstrate that dietary GLDA may have enhanced zinc solubility in the gastrointestinal tract and, subsequently enhanced availability for absorption, resulting in improved nutritional zinc status in zinc deficient diets. As such, GLDA can be an effective nutritional tool to reduce supplemental zinc levels in broiler diets thereby maintaining health and performance while reducing the environmental footprint of food producing animals.

Chelating agents can be used to improve the nutritional availability of trace minerals within the gastrointestinal tract. This study was conducted to determine the effect of a novel chelating agents, L-glutamic acid N,N-diacetic acid ( GLDA ), a biodegradable alternative to ethylenediaminetetraacetic acid on the nutritional bioavailability of zinc in broilers. Twelve dietary treatments were allocated to 96 pens in a randomized block design. Pens contained 10 Ross 308 male broilers in a factorial design with 6 incremental zinc levels (40, 45, 50, 60, 80, and 120 ppm of total Zn), with and without inclusion of GLDA (0 and 100 ppm) as respective factors. Experimental diets were supplied from day 7 to 21/22 and serum, liver and tibia Zn content were determined in 3 birds per pen. Growth performance and liver characteristics were not affected by dietary treatments, but both supplemental Zn and GLDA enhanced tibia and serum zinc concentration. The positive effect of GLDA was observed at all levels of the dietary Zn addition. The amount of zinc needed to reach 95% of the asymptotic Zn response was determined using nonlinear regression. When GLDA was included in the diet, based on tibia Zn, the same Zn status was achieved with a 19 ppm smaller Zn dose while based on serum Zn this was 27 ppm less Zn. Dietary GLDA reduces supplemental Zn needs to fulfill nutritional demands as defined by tibia Zn and serum Zn response. Considering the positive effect on the nutritional availability of Zn in broilers, GLDA presents an opportunity as biodegradable additive, to reduce Zn supplementation to livestock and thereby reducing Zn excretion into the environment, while fulfilling the nutrition Zn needs of farmed animals.

No abstract

The novel chelator, L-glutamic acid, N,N-diacetic acid ( GLDA ) can be used as a dietary ingredient to safely reduce Zn supplementation in complete feed, without compromising the Zn status of farm animals. The objective of this study was to study dietary tolerance, bioaccumulation, and evaluate the safety of GLDA when supplemented in broiler diets at 0, 100, 300, 1000, 3,000, and 10,000 mg/kg. A total of 480 one-day-old Ross 308 male broilers were randomly allocated to 48 pens and fed one of the 6 experimental diets. Production performance was used to assess tolerance to the additive. At trial end, toxicity was evaluated using hematology, plasma biochemistry (n = 144) and gross necropsy (n = 48). Residue levels of GLDA were assessed in liver, kidney and breast tissue of birds used for necropsy. Performance showed an increase ( P < 0.05) in body weight for GLDA inclusion at 300 mg/kg. A decrease on the measured performance parameters was found for the 10,000 mg/kg GLDA inclusion level ( P < 0.05). The additive was added as a tetra-sodium salt, leading to sodium levels being 2.5 times higher in the latter treatment compared to the control diet which may have led to impaired intestinal barrier function. Mortality was not different between treatments. Residue levels for GLDA at the highest inclusion indicate that 0.0005% of total GLDA consumption is accumulated in breast tissue. Higher values of GLDA were found in kidney and liver at the highest inclusion level, potentially confirming that the small fraction of GLDA absorbed was readily excreted by the animal. At 100 and 300 mg/kg GLDA inclusion there were negligible amounts of GLDA present in all tissues measured. The present experiment demonstrated a high dietary tolerance to GLDA in broilers and indicated that GLDA does not pose a significant risk to food safety when supplemented below 3,000 mg/kg.

This study compared the Zn response in selected tissues of weaned piglets fed L-glutamic acid, N,N-diacetic acid (GLDA), while challenged with short-term subclinical Zn deficiency (SZD). During a total experimental period of eight days, 96 piglets were fed restrictively (450 g/d) a high phytate (9 g/kg) diet containing added Zn at 0, 5, 10, 15, 20, 25, 45 and 75 mg/kg with and without 200 mg/kg of GLDA. No animals showed signs of clinical Zn deficiency and no phenotypical differences were observed. Broken line analysis of Zn status parameters such as liver Zn and apparently absorbed Zn indicated that the gross Zn requirement threshold was around 55 mg/kg diet. Supplementation of Zn above this threshold led to a saturation of the response in apparently absorbed Zn and linear increase in liver Zn. Bone and serum Zn responded to the dose in a linear fashion, likely due to the time-frame of Zn homoeostatic adaptation. Inclusion of GLDA into the diets yielded a higher intercept for bone Zn (P < 0·05). Liver Zn accumulation and MT1A gene expression was higher for piglets receiving GLDA (P < 0·05), indicating higher Zn influx. This study indicates that a strong chelator such as GLDA mitigates negative effects of phytate in plant-based diets, by sustaining Zn solubility, thereby improving nutritional Zn availability.